Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands.
Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands; Department of Cardiothoracic Surgery, Medical Center Amsterdam, the Netherlands.
Ann Thorac Surg. 2020 Jun;109(6):1858-1863. doi: 10.1016/j.athoracsur.2019.09.009. Epub 2019 Oct 5.
We report procedural and early results in the Netherlands of the Relay Branch device (Terumo Aortic, Sunrise, FL) for total endovascular repair of the aortic arch.
Between 2014 and 2018, all consecutive patients who received the Aortic Relay double-branched stent graft in the Netherlands were included in a multicenter, retrospective registry.
The Relay Branch device was used in 11 patients to treat saccular (n = 4), fusiform (n = 5), or false aneurysms (n = 2) in the aortic arch. Patients were deemed unfit or extreme high-risk for open (redo) surgery. The brachiocephalic trunk and left common carotid artery were branched using a retrograde approach in all cases. Additional surgical left subclavian artery revascularization was performed in 8 patients. The main device and the branches were successfully introduced, positioned, and deployed with complete exclusion of the aortic pathology in all patients (100% technical success). There was no retrograde type A dissection or conversion to open surgery. Two procedure-related deaths occurred, both caused by perioperative or postoperative strokes. There were 2 minor strokes with full recovery. One patient recovered from transient paraplegia after spinal fluid drainage. No permanent paraplegia was observed. Follow-up imaging showed persistent adequate exclusion of aortic arch pathology. Mean follow-up was 17 months (range, 3-42 months).
Total endovascular aortic arch repair using the Relay Branch device is technically feasible and effective in excluding aortic arch pathology. The observed stroke rate in the initial experience, however, was considerable. Although appealing, this new less-invasive technique should be carefully introduced and its progress thoroughly evaluated.
我们报告了荷兰使用 Relay 分支装置(Terumo Aortic,Sunrise,FL)进行全腔内主动脉弓修复的手术过程和早期结果。
在 2014 年至 2018 年期间,荷兰所有接受 Aortic Relay 双分支支架移植物治疗的连续患者均被纳入一个多中心回顾性注册研究。
Relay 分支装置在 11 例患者中用于治疗主动脉弓的囊状(n=4)、梭形(n=5)或假性动脉瘤(n=2)。患者被认为不适合或极高风险接受开放(再次)手术。所有病例均采用逆行技术对头臂干和左颈总动脉进行分支。8 例患者还进行了额外的外科左锁骨下动脉血运重建。所有患者(100%技术成功率)均成功引入、定位和展开主装置和分支,完全排除主动脉病变。无逆行 A 型夹层或转为开放手术。2 例与手术相关的死亡均由围手术期或术后中风引起。有 2 例轻微中风,完全恢复。1 例患者经脑脊液引流后恢复短暂性截瘫。无永久性截瘫。随访影像学显示主动脉弓病变持续得到充分排除。平均随访时间为 17 个月(范围 3-42 个月)。
使用 Relay 分支装置进行全腔内主动脉弓修复在技术上是可行且有效的,可以排除主动脉弓病变。然而,在最初的经验中观察到的中风发生率相当高。尽管这种新的微创技术很有吸引力,但应谨慎引入,并彻底评估其进展。